Stabilux Biosciences Revenue and Competitors

StabiLux Biosciences® produces High-Brightness Dyes™ that are poised to unleash the next 50 years of biomedical innovation. Stabilux Biosciences®, a Michigan Technological University (MTU) spinout, has developed proprietary, high-brightness fluorophores (dyes) for biomedical applications. The result is NovoLux® High-Brightness Dyes™ , 2X to 1,000X brighter than any commercial dye, increasing the detection sensitivity of multi-color flow cytometry. Our NovoLux® dyes can be used with existing flow cytometry equipment, and allow researchers to detect what was previously undetectable. NovoLux® High-Brightness Dyes™ also have a novel feature, tunable brightness, meaning that the precise increase in brightness of a single color can be made allowing rare events to be detected without interfering with adjacent signals. Leveraging $2.7M in funding , 5 years of development, and feedback from early customers, StabiLux® is looking to raise its next round of funding.